Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients

Nikoletta Lendvai, Sacha Gnjatic, Erika Ritter, Michael Mangone, Wayne Austin, Karina Reyner, David Jayabalan, Ruben Niesvizky, Sundar Jagannath, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old and Hearn Jay Cho
Nikoletta Lendvai
1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sacha Gnjatic
2The Ludwig Institute for Cancer Research, New York Branch, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Ritter
2The Ludwig Institute for Cancer Research, New York Branch, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Mangone
1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wayne Austin
1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karina Reyner
1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Jayabalan
3Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruben Niesvizky
4Division of Hematology/ Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sundar Jagannath
5Multiple Myeloma Program, Bone Marrow and Blood Stem Cell Transplantation, St. Vincent's Comprehensive Cancer Center, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nina Bhardwaj
1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Selina Chen-Kiang
3Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lloyd J. Old
2The Ludwig Institute for Cancer Research, New York Branch, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hearn Jay Cho
1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published January 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: to

AbstractFull-text HTMLPDF
Total000

Cited By

Article Information

Volume 10, Issue 1, pp.

PubMed 
20108890

Published By 
Cancer Research Institute
Print ISSN 
1424-9634
Online ISSN 
1424-9634
History 
  • Received August 20, 2009
  • Accepted September 17, 2009
  • Published first January 1, 2010.

Copyright & Usage 
Copyright © 2010 by Hearn Jay Cho

Author Information

  1. Nikoletta Lendvai1,*,
  2. Sacha Gnjatic2,
  3. Erika Ritter2,
  4. Michael Mangone1,
  5. Wayne Austin1,
  6. Karina Reyner1,
  7. David Jayabalan3,
  8. Ruben Niesvizky4,
  9. Sundar Jagannath5,
  10. Nina Bhardwaj1,
  11. Selina Chen-Kiang3,
  12. Lloyd J. Old2 and
  13. Hearn Jay Cho1
  1. 1New York University Cancer Institute, New York University School of Medicine, New York, NY, USA
  2. 2The Ludwig Institute for Cancer Research, New York Branch, New York, NY, USA
  3. 3Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA
  4. 4Division of Hematology/ Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
  5. 5Multiple Myeloma Program, Bone Marrow and Blood Stem Cell Transplantation, St. Vincent's Comprehensive Cancer Center, New York, NY, USA
  1. Address correspondence to: Hearn Jay Cho, New York University Cancer Institute, Smilow 1304, 522 First Avenue, New York, NY 10016, USA, E-mail: hearn.jay.cho{at}nyumc.org
  1. Communicated by: V Cerundolo

  • ↵* Present address: Department of Medicine, Hematology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

View Full Text
PreviousNext
Back to top
Cancer Immunity Archive: 10 (1)
January 2010
Volume 10, Issue 1
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients
Nikoletta Lendvai, Sacha Gnjatic, Erika Ritter, Michael Mangone, Wayne Austin, Karina Reyner, David Jayabalan, Ruben Niesvizky, Sundar Jagannath, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old and Hearn Jay Cho
Cancer Immun January 1 2010 (10) (1) 4;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients
Nikoletta Lendvai, Sacha Gnjatic, Erika Ritter, Michael Mangone, Wayne Austin, Karina Reyner, David Jayabalan, Ruben Niesvizky, Sundar Jagannath, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old and Hearn Jay Cho
Cancer Immun January 1 2010 (10) (1) 4;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • NY-ESO-1–specific immunological pressure and escape in a patient with metastatic melanoma
  • Hsp72 mediates stronger antigen-dependent non-classical MHC class Ib anti-tumor responses than hsc73 in Xenopus laevis
  • Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement